Field Trip Health Ltd. Provides Update on FT-104, Its Next Generation Psychedelic Molecule in Development
- Thursday, October 29, 2020, 7:14
- PR Newswire
- Add a comment
Results confirm that Field Trip’s novel psychedelic molecule is similar in potency to psilocybin but with shorter duration of psychoactivity making it a potentially preferable option for psychedelic therapies TORONTO, Oct. 29, 2020 /PRNewswire/ — Field Trip Health Ltd. (CSE: FTRP) (OTC:…
About the Author
admin has written 20655 stories on this site.